On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Momenta Pharmaceuticals (United States)

InstitutionResearch output, impact & collaborations

Momenta Pharmaceuticals (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Momenta Pharmaceuticals (United States)?

ScholarIQrecord summary

Momenta Pharmaceuticals (United States) is a research organisation in Cambridge, US. OpenAlex records 187 works and 105,290 citations for it. 83 researchers list it as their most recent affiliation.

How many works does Momenta Pharmaceuticals (United States) have?

ScholarIQindexed works

Momenta Pharmaceuticals (United States) has 187 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Momenta Pharmaceuticals (United States) have?

ScholarIQcitation count

Momenta Pharmaceuticals (United States) has 105,290 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Momenta Pharmaceuticals (United States)?

ScholarIQresearcher count

Momenta Pharmaceuticals (United States) has 83 researchers in the ScholarIQ index.

What is the average h-index at Momenta Pharmaceuticals (United States)?

ScholarIQavg h-index

Momenta Pharmaceuticals (United States) has an average h-index of 6 in OpenAlex.

What is the ROR of Momenta Pharmaceuticals (United States)?

ScholarIQror

The ROR for Momenta Pharmaceuticals (United States) is on the source record.

What is the OpenAlex record for Momenta Pharmaceuticals (United States)?

ScholarIQopenalex

The OpenAlex for Momenta Pharmaceuticals (United States) is on the source record.

Who are the most-cited researchers behind Momenta Pharmaceuticals (United States)?

ScholarIQtop researchers by citations
1
Jennifer Gudeman · Sleep and Wakefulness Research
88 works117 citations

What are the most-cited papers on Momenta Pharmaceuticals (United States)?

ScholarIQmost cited works
Demographic characteristics and comorbidities of patients with narcolepsy: a propensity-matched cohort study
Melissa C. Lipford, Wui Ip, Samir Awasthi, James L. Moore, Maja Tippmann‐Peikert, Shahir Asfahan, Praveen Kumar, Gajinder Pal Singh, Jennifer Gudeman
SLEEP Advances. 202414 CitationsOPEN ACCESS
Efficacy of once-nightly sodium oxybate (FT218) in narcolepsy type 1 and type 2: post hoc analysis from the Phase 3 REST-ON Trial
Yves Dauvilliers, Thomas Roth, Richard Bogan, Michael J. Thorpy, Anne Marie Morse, Asim Roy, Jordan Dubow, Jennifer Gudeman
SLEEP. 202313 CitationsOPEN ACCESS
Randomized, crossover, open-label study of the relative bioavailability and safety of FT218, a once-nightly sodium oxybate formulation: Phase 1 study in healthy volunteers
Richard Bogan, Michael J. Thorpy, John W. Winkelman, Jordan Dubow, Jennifer Gudeman, David Seiden
Sleep Medicine. 202212 CitationsOPEN ACCESS
A Survey of People Living with Narcolepsy in the USA: Path to Diagnosis, Quality of Life, and Treatment Landscape from the Patient’s Perspective
Luis E. Ortiz, Anne Marie Morse, Lois E. Krahn, Maggie Lavender, Matthew Horsnell, Dianna Cronin, Beth Schneider, Jennifer Gudeman
CNS Drugs. 202511 CitationsOPEN ACCESS

How much of the research on Momenta Pharmaceuticals (United States) is open access?

ScholarIQopen access share
83%OPEN ACCESS
Gold
25%
Green
0%
Hybrid
50%
Bronze
8%
Closed
17%

Related on ScholarIQ

470M+ articles · 14-day free trial